ReviewFrontiers in oncology2020

GPI-AP: Unraveling a New Class of Malignancy Mediators and Potential Immunotherapy Targets.

Nada H Hussein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.